文献速递结核与非结核分枝杆菌发热待查

抗干扰素γ自身抗体患者中的错误诊断

Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
PubMed 文献 · Clin Microbiol Infect · 2020-02-28

本研究纳入六家医院154例不明原因机会性感染成人患者,发现50例(71%)播散性非结核分枝杆菌感染患者存在中和性抗干扰素γ自身抗体。从发病到识别dNTM的中位时间为1.6年(范围0.25-19年),错误初步诊断导致频繁使用抗结核方案(60%)、免疫抑制剂(48%)和全身化疗(2%)。多因素分析显示多骨病变和白细胞增多是病例患者的独立相关因素,而对照组分枝杆菌血流感染率更高。

要点

  • 播散性非结核分枝杆菌感染患者中抗干扰素γ自身抗体阳性率高,应警惕该免疫缺陷。
  • 错误初步诊断常见,导致不恰当的抗结核治疗、免疫抑制和化疗。
  • 多骨病变和白细胞增多可能提示抗干扰素γ自身抗体相关免疫缺陷。

核心结论

  • 抗干扰素γ自身抗体患者错误初步诊断率高,导致频繁不恰当管理,需提高临床医生认识。

研究设计与样本

  • 本研究纳入六家医院154例不明原因机会性感染成人患者,识别其中具有中和性抗干扰素γ自身抗体的病例,并与对照组比较。

主要发现

  • 70例播散性非结核分枝杆菌感染患者中50例(71%)检测到中和性抗干扰素γ自身抗体,84例无dNTM患者均未检测到。
  • 从发病到识别dNTM的中位时间为1.6年(范围0.25-19年)。
  • 50例病例中,错误初步诊断导致使用抗结核方案(60%,30/50)、免疫抑制剂(48%,24/50)和全身化疗(2%,10/50)。
  • 多因素分析显示病例患者较对照组更易出现多骨病变(调整OR 27.16;95%CI 1.21-609.59)和白细胞增多(调整OR 1.48;95%CI 1.12-1.95);对照组分枝杆菌血流感染率更高(调整OR 0.05;95%CI 0.00-0.66)。

临床怎么用

  • 对不明原因机会性感染患者,尤其伴多骨病变或白细胞增多者,应考虑检测中和性抗干扰素γ自身抗体。
  • 避免在未明确诊断前经验性使用抗结核药物、免疫抑制剂或化疗,以防延误正确治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Early diagnosis of adult-onset immunodeficiency associated with neutralizing anti-interferon-gamma autoantibodies (anti-IFNγ Abs) remains difficult given the lack of a distinctive phenotype and a routine test. This study aimed to investigate the determinants of incorrect tentative diagnoses and useful clues for early disease recognition. METHODS: This study enrolled adult patients who had unexplained opportunistic infections diagnosed at six hospitals and identified those having neutralizing anti-IFNγ Abs (cases). Demographics, medical history, initial presentations and laboratory data, causative pathogens, tentative diagnoses, and treatment were analysed and compared among individuals having neutralizing anti-IFNγ Abs (cases) and those without (controls). RESULTS: Among the 154 patients enrolled, neutralizing anti-IFN-γ Abs were detected in 50 (71%) of 70 patients with disseminated non-tuberculous mycobacterial infection (dNTM) but not in 84 patients without dNTM. The median time from disease onset to the recognition of dNTM associated with neutralizing anti-IFNγ Abs was 1.6 years (range, 0.25-19 years). Incorrect tentative diagnoses resulted in the administration of anti-tuberculosis regimens (60%, 30/50), immunosuppressants (48%, 24/50), and systemic chemotherapy (2%, 10/50) to the 50 cases. Multivariate analysis revealed that case patients were more likely than controls to present with multiple bone lesions (adjusted odds ratio (OR), 27.16; 95% confidence interval (CI), 1.21-609.59) and leukocytosis (adjusted OR, 1.48; 95% CI, 1.12-1.95); however, the controls had a higher rate of mycobacterial bloodstream infection (adjusted OR, 0.05; 95% CI 0.00-0.66). CONCLUSIONS: The high rate of incorrect tentative diagnoses led to frequent inappropriate management in patients with neutralizing anti-IFNγ Abs, and highlighted the need for increased awareness among clinicians.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Wu UI, Wang JT, Sheng WH, et al. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies. Clin Microbiol Infect. 2020. PMID: 32120037. doi:10.1016/j.cmi.2020.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。